Improving detection of blindness in childhood: the British Childhood Vision Impairment study

Jugnoo S Rahi1, Phillippa M Cumberland, Catherine S Peckham

  • 1University College London, Institute of Child Health, MRC Centre of Epidemiology for Child Health, 30 Guilford St, London WC1N 1EH, UK. j.rahi@ich.ucl.ac.uk

Pediatrics
|September 22, 2010
PubMed

Insights

Early detection of severe visual impairment or blindness (SVI/BL) in children is crucial. Many cases are missed by routine screening, highlighting the need for improved parental awareness and enhanced clinical surveillance programs.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Public Health

Background:

  • Established childhood vision screening programs exist in industrialized nations, but their performance is not well understood.
  • Investigating the presentation, detection, and early treatment of severe visual impairment or blindness (SVI/BL) in children is essential for improving outcomes.

Purpose of the Study:

  • To analyze the patterns of presentation, detection, and early management of a nationally representative cohort of children with SVI/BL in the UK.
  • To evaluate the effectiveness of current screening and surveillance methods for childhood visual impairment.

Main Methods:

  • Active surveillance of children under 16 with new SVI/BL diagnoses in the UK during 2000.
  • Data collection included sociodemographics, detection methods, co-occurring disorders, ophthalmic findings, and early management.

Main Results:

  • 65% of 439 children were diagnosed before age 1; 28% were non-white; 40% from the most deprived areas.
  • 77% had associated non-ophthalmic disorders. Parents suspected blindness in 47%, while health professionals noted signs in 70%.
  • Routine screening detected 25% of isolated SVI/BL; clinical surveillance diagnosed 46% of SVI/BL with co-occurring conditions.

Conclusions:

  • The patient journey for visually impaired children is significantly impacted by additional health issues.
  • Enhanced parental education on visual development and evidence-based clinical surveillance programs are needed for at-risk children.
Abstract